Interact to see
Advertisement
Advertisement
GSBDX vs NRGSX
GSBDX vs NRGSX Comparison
Open Charts GSBDX vs NRGSX
Goldman Sachs Small Cap Growth A
Price$16.37
Change-$0.03 (-0.18%)
VolumeN/A
Net Assets383.86M
Neuberger Berman Genesis R6
Price$62.80
Change+$0.25 (+0.40%)
VolumeN/A
Net Assets8.71B
GSBDX vs NRGSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GSBDX vs. NRGSX commentary
Oct 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSBDX is a Hold and NRGSX is a Hold.
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 8.71B vs. GSBDX (384M). NRGSX pays higher dividends than GSBDX: NRGSX (0.06) vs GSBDX (0.00). GSBDX was incepted earlier than NRGSX: GSBDX (6 years) vs NRGSX (13 years). GSBDX (1.66) is less costly to investors than NRGSX (0.74). GSBDX is a more actively managed with annual turnover of: 69.00 vs. NRGSX (13.00). NRGSX has a lower initial minimum investment than GSBDX: NRGSX (0) vs GSBDX (1000). GSBDX annual gain was more profitable for investors over the last year : 6.30 vs. NRGSX (-10.12). GSBDX return over 5 years is better than : 19.55 vs. NRGSX (-2.32).
| GSBDX | NRGSX | GSBDX / NRGSX | |
| Total Expense Ratio | 1.23 | 0.74 | 166% |
| Annual Report Gross Expense Ratio | 1.66 | 0.74 | 224% |
| Fund Existence | 6 years | 13 years | - |
| Gain YTD | 7.415 | -3.902 | -190% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 384M | 8.71B | 4% |
| Annual Yield % from dividends | 0.00 | 0.06 | - |
| Returns for 1 year | 6.30 | -10.12 | -62% |
| Returns for 3 years | 52.71 | 5.90 | 893% |
| Returns for 5 years | 19.55 | -2.32 | -842% |
| Returns for 10 years | N/A | 10.24 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 73.75 | 0.46 | +0.63% |
| Janus Henderson Global Life Sciences A | |||
| GGCCX | 102.84 | 0.38 | +0.37% |
| Gabelli Growth C | |||
| GMCUX | 16.77 | 0.04 | +0.24% |
| Goldman Sachs Small/Mid Cap Equity R6 | |||
| RLEFX | 38.98 | 0.04 | +0.10% |
| American Funds American Balanced R5E | |||
| MSECX | 11.32 | 0.01 | +0.09% |
| Morgan Stanley Inst International Eq C | |||